AML Minimal Residual Disease Table

Preferred Label : AML Minimal Residual Disease Table;

NCIt synonyms : Acute Myeloid Leukemia Minimal Residual Disease Table; MRD;

NCIt related terms : Minimal Residual Disease Table;

NCIt definition : Terminology created by EVS and PCDC to support the AML Minimal Residual Disease Table.;

NCI Metathesaurus CUI : CL1407300;

Details

Origin ID

C173236;

UMLS CUI

C5400939;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
concept_is_in_subset
- AML Table Terminology [NCIt concept]
- PCDC Terminology [NCIt concept]
subset_includes_concept
- Age in Days at Measurable Residual Disease Assessment [NCIt concept]
- Biallelic CEBPA Gene Mutation [NCIt concept]
- Blood Sample [NCIt concept]
- Bone Marrow Sample [NCIt concept]
- CEBPA Gene Mutation [NCIt concept]
- Consolidation Therapy [NCIt concept]
- Disease Phase [NCIt concept]
- Disease Phase Number [NCIt concept]
- FLT3 Internal Tandem Duplication [NCIt concept]
- FLT3 Tyrosine Kinase Domain Point Mutation [NCIt concept]
- Flow Cytometry [NCIt concept]
- Flow Cytometry Different from Normal [NCIt concept]
- Flow Cytometry Type [NCIt concept]
- Flow Cytometry for Leukemia-Associated Immunophenotypes [NCIt concept]
- GATA1 Gene Mutation [NCIt concept]
- Hematopoietic Cell Transplantation Conditioning Regimen [NCIt concept]
- Induction Therapy [NCIt concept]
- Initial Diagnosis [NCIt concept]
- Intensification Therapy [NCIt concept]
- KIT Exon 17 Mutation [NCIt concept]
- KIT Exon 8 Mutation [NCIt concept]
- KIT Gene Mutation [NCIt concept]
- KMT2A Gene Rearrangement [NCIt concept]
- KRAS Gene Mutation [NCIt concept]
- Loss of Chromosome 17p [NCIt concept]
- Maintenance Therapy [NCIt concept]
- Measurable Residual Disease Method [NCIt concept]
- Measurable Residual Disease Molecular Marker [NCIt concept]
- Measurable Residual Disease Response [NCIt concept]
- Measurable Residual Disease Sample Source [NCIt concept]
- Measurable Residual Disease Sensitivity [NCIt concept]
- Measurable Residual Disease Unit [NCIt concept]
- Measurable Residual Disease Value [NCIt concept]
- Medication Course Number [NCIt concept]
- Monoallelic CEBPA Gene Mutation [NCIt concept]
- Monosomy 5 [NCIt concept]
- Monosomy 7 [NCIt concept]
- NPM1 Gene Mutation [NCIt concept]
- NRAS Gene Mutation [NCIt concept]
- Next Generation Sequencing [NCIt concept]
- Non-KMT2A MLLT10 Rearrangement Positive [NCIt concept]
- Not Reported [NCIt concept]
- Other [NCIt concept]
- PCDC Subject Identifier [NCIt concept]
- PTPN11 Gene Mutation [NCIt concept]
- Palliative Therapy [NCIt concept]
- Percent Unit [NCIt concept]
- Prephase Chemotherapy Treatment [NCIt concept]
- Protocol Treatment Course [NCIt concept]
- RUNX1 Gene Mutation [NCIt concept]
- Real Time PCR [NCIt concept]
- Recurrent Disease [NCIt concept]
- Trisomy 8 [NCIt concept]
- Unknown [NCIt concept]
- WT1 Gene Mutation [NCIt concept]
- del(13q14-q21) [NCIt concept]
- del(5q31-q32) [NCIt concept]
- der12p [NCIt concept]
- inv(16)(p13.1;q22) [NCIt concept]
- inv(16)(p13.3;q24.3) [NCIt concept]
- inv(3)(q21.3;q26.2) [NCIt concept]
- t(10;11)(p11.2;q23) [NCIt concept]
- t(10;11)(p12;q23) [NCIt concept]
- t(11;15)(p15;q35) [NCIt concept]
- t(11;17) [NCIt concept]
- t(11;19)(q23.3;p13.1) [NCIt concept]
- t(11;19)(q23.3;p13.3) [NCIt concept]
- t(11;19)(q23;p13) [NCIt concept]
- t(15;17)(q24;q21) [NCIt concept]
- t(16;16)(p13.1;q22) [NCIt concept]
- t(16;21)(p11;q22) [NCIt concept]
- t(16;21)(q24;q22) [NCIt concept]
- t(1;11)(q21;q23) [NCIt concept]
- t(1;22) [NCIt concept]
- t(2;12) [NCIt concept]
- t(3;12)(q23;p12.3) [NCIt concept]
- t(3;3)(q21.3;q26.2) [NCIt concept]
- t(3;5)(q25;q34) [NCIt concept]
- t(4;11)(q21;q23.3) [NCIt concept]
- t(5;11)(q35;p15) [NCIt concept]
- t(6;11)(q27;q23) [NCIt concept]
- t(6;9)(p22.3;q34.1) [NCIt concept]
- t(7;12)(q36;p13) [NCIt concept]
- t(8;16) [NCIt concept]
- t(9;11)(p21.3;q23.3) [NCIt concept]
- t(9;22)(q34.1;q11.2) [NCIt concept]
- t(v;11q23.3) [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients